MEDICHEM LIFE SCIENCES INC
POS AM, EX-23.1, 2000-10-26
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: MEDICHEM LIFE SCIENCES INC, POS AM, 2000-10-26
Next: MEDICHEM LIFE SCIENCES INC, POS AM, EX-23.2, 2000-10-26



<PAGE>

                                                                    Exhibit 23.1

--------------------------------------------------------------------------------

Consent of KPMG LLP

The Board of Directors
MCR Holdings, Inc.:

The audits referred to in our report dated February 3, 2000, except as to Note
14 which is as of October 25, 2000, included the related financial statement
schedules as of December 31, 1999, and for each of the years in the three-year
period ended December 31, 1999, included in the registration statement on Form
S-1 filed by MediChem Life Sciences, Inc. These financial statement schedules
are the responsibility of the Company's management. Our responsibility is to
express an opinion on these financial statement schedules based on our audits.
In our opinion, such financial statement schedules, when considered in relation
to the basic consolidated financial statements taken as a whole, present fairly
in all material respects the information set forth therein.

We consent to the use of our reports herein and to the reference to our firm
under the headings "Selected Financial Data" and "Experts" in the prospectus.

                                          /s/ KPMG LLP

Chicago, Illinois
October 25, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission